Delivery Order SPE2DB22D3501-SPE2DB24FTZ68
Award Date 12/29/23
Potential Completion Date 1/23/24
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,621.20 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide 4,563,910,634 units of XEOMIN 100 unit vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- The Defense Logistics Agency (DLA) awarded a $10,485.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,496,211 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) has awarded a $40,462.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,020,471 XEOMIN 100 unit vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,621.20, is for the provision of 4,563,451,765 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,747,877 units of XEOMIN 100 unit vials. The $1,310.60 contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also received a separate indefinite delivery contract (IDC) from DLA valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $44,036.16 contract is for the delivery of 4,563,871,394 vials of the pharmaceutical product XEOMIN 100 UNIT. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of XEOMIN 100 unit vials. The contract, with a ceiling value of $12,319.64, is a firm fixed-price delivery order contract with a period of performance through June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,856,632 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has a total potential value of $1,048.48 and a completion date of March 22, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is the prime contractor and will be performing the work at its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,145.50 to the Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 4564421570 units of XEOMIN 200 UNIT VIALS. The contract has a firm fixed price and an ultimate completion date of May 17, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTZ68Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $7,125.00 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,563,205,093 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current delivery order does not have a set-aside designation.
Generated 9/13/24, 9:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 12/29/23 |